Immune · Reference
FORTIFY Blend for Men: Immunity, Testosterone, Sport and What the Research Covers
This page covers what FORTIFY is, what each component's research does and does not show, the questions men ask most (testosterone, TRT, training and recovery, sport, fertility, autoimmune conditions), what a physician rules out first in men who feel run down, and how Pepti supplies it. For the full product reference see what is the FORTIFY blend; for the evidence benefit by benefit, FORTIFY blend benefits.
No study has tested FORTIFY in men, or in anyone: it is four separately studied peptides, thymosin alpha-1, BPC-157, KPV and LL-37, in one vial, and none of their research reports results specific to men. The component with a real human record is thymosin alpha-1, whose randomised trials over more than thirty years were in hepatitis B, sepsis and other diseases, with a negative result in the largest, and none in healthy adults, which is the use most men ask about. For men the practical points are what FORTIFY is not, a testosterone booster, a muscle or recovery peptide, or a treatment for infection, and sport: FORTIFY contains BPC-157, named on the WADA Prohibited List at all times, so it is not an option for anyone who is drug tested. Compounded FORTIFY is a prescription injection and is not FDA approved.
This page covers what FORTIFY is, what each component's research does and does not show, the questions men ask most (testosterone, TRT, training and recovery, sport, fertility, autoimmune conditions), what a physician rules out first in men who feel run down, and how Pepti supplies it. For the full product reference see what is the FORTIFY blend; for the evidence benefit by benefit, FORTIFY blend benefits.
FORTIFY Blend for Men
The short answer
| Question | What the research shows | Strength of evidence |
|---|---|---|
| Has FORTIFY been studied in men? | No study of the blend in anyone | None for the combination |
| Immune function | Thymosin alpha-1 trials in hepatitis B (very low certainty, 2026 Cochrane review) and sepsis (the 1,106-patient BMJ 2025 trial found no clear mortality benefit) | Human, in sick populations; none in healthy adults |
| Gut inflammation | BPC-157 animal work and early-phase human work; KPV mouse colitis models | Mostly animal |
| Does it raise testosterone? | None of the four is a hormone or a secretagogue | Not a testosterone booster |
| Muscle or recovery | Nothing in the thymosin alpha-1 research; that is TB-500, a different molecule | Not a recovery blend |
| Alongside TRT | No study of the combination; no interaction described | None |
| Tested sport | Prohibited: BPC-157 is named under S0, prohibited at all times | Settled |
The honest summary: one component with human trials in sick people, three with mostly animal and cell literatures, no human trial of the blend, nothing that makes it a men's hormone product, and a hard stop for anyone who is drug tested.
FORTIFY Blend for Men
What FORTIFY is
| Component | Per vial | Per 25 unit dose | What it is |
|---|---|---|---|
| Thymosin alpha-1 | 5 mg | 0.25 mg | 28-amino-acid peptide the thymus makes from prothymosin alpha |
| BPC-157 | 5 mg | 0.25 mg | 15-amino-acid fragment of a protein from human gastric juice |
| KPV | 2 mg | 0.1 mg | The C-terminal tripeptide of alpha-MSH |
| LL-37 | 1 mg | 0.05 mg | The only human cathelicidin antimicrobial peptide |
The rationale prescribers give is that getting sick often and recovering slowly are rarely one problem: immune recognition may be sluggish, the gut lining may be inflamed, and inflammation that never resolves keeps the system busy. Thymosin alpha-1 is the component described as sharpening immune recognition, LL-37 the body's own first-line antimicrobial, BPC-157 the gut-lining component and KPV the inflammation brake. That is a rationale, not a finding.
FORTIFY Blend for Men
What research has looked at
Thymosin alpha-1: disease trials, not healthy men
Thymalfasin, the synthetic version, has been sold outside the United States since the 1990s and is approved in a number of countries, mainly for chronic hepatitis B and as a vaccine adjuvant. A 2026 Cochrane review pooled ten randomised trials and 1,349 participants with chronic hepatitis B and reported that thymosin alpha-1 may reduce all-cause mortality and serious adverse events, at very low certainty for almost every outcome. In sepsis, the 2013 ETASS trial of 361 patients reported a difference of marginal significance; the follow-up, TESTS, a double-blind phase 3 trial of 1,106 adults in the BMJ in 2025, found 28-day mortality of 23.4 percent against 24.1 percent and no clear evidence of a mortality benefit.
What it shows. A long human record in sick populations, with consistent tolerability.
What it does not show. Any effect in otherwise healthy men who get sick often, or results reported separately for men. That use rests on clinical judgement. More is in thymosin alpha-1 for men.
BPC-157 and KPV: the gut components
BPC-157's largest literature is animal work on protection of the gut lining and inflammatory bowel models, plus early-phase human work for inflammatory bowel indications. KPV's evidence is cell work and mouse models of colitis and skin inflammation; there is no human trial of KPV for any indication. See KPV for men.
LL-37: topical trials only
Two randomised, placebo-controlled trials of topical LL-37 on hard-to-heal venous leg ulcers have been published: a 2014 first-in-man trial of 34 patients with mixed results by concentration, and a 2021 phase IIb trial of 148 patients that found no significant improvement overall. There are no human trials of injectable LL-37.
FORTIFY Blend for Men
What changes for men
It is not a testosterone booster
None of FORTIFY's four components is a hormone or a growth hormone secretagogue, and none is described as acting on testosterone or any hormone axis. Cell research describes BPC-157 increasing growth hormone receptor expression in tendon fibroblasts, which is different from raising a hormone level. If low testosterone is the question, peptides for testosterone covers what has and has not been studied.
It is not a recovery blend, and it is not TB-500
The names cause constant confusion. Thymosin alpha-1 is not thymosin beta-4 or its fragment TB-500, which is studied around tissue repair and is what men looking for help with a tendon or old injury usually mean. Nothing in the thymosin alpha-1 research describes muscle, strength, tendon repair or training recovery. For a soft-tissue injury, KLOW pairs BPC-157 and KPV with GHK-Cu and TB-500, and the BPC-157 + TB-500 stack is the injury-only option. See thymosin alpha-1 vs TB-500.
Alongside testosterone therapy
No study has looked at FORTIFY or any of its components alongside testosterone replacement, and no interaction is described, but there is no established interaction list for any of them. List your testosterone prescription and whoever manages it on your intake so your physician can review them together. See can you take peptides with testosterone.
Autoimmune disease and immunosuppression
This is the caution that matters most, for men and women alike. Thymosin alpha-1 modulates immune signalling, and a 2007 paper in Nature reported that in psoriasis LL-37 binds self-DNA and drives plasmacytoid dendritic cells to trigger inflammation. A diagnosed autoimmune condition, psoriasis included, or any immunosuppressive treatment needs specialist input before FORTIFY is prescribed.
Tanning and skin colour
KPV is the tail of alpha-MSH, the hormone that drives pigmentation, but the isolated tripeptide is reported to keep its anti-inflammatory activity and lose the pigment effect. FORTIFY is not expected to darken skin or moles, and it is not a tanning product.
Fertility
Nothing in the live research looks at thymosin alpha-1, BPC-157, KPV or LL-37 and male fertility in either direction. That is an absence of data, not evidence of safety. If you are trying to conceive with a partner, tell your physician before starting. See do peptides affect fertility.
Tested sport
FORTIFY is prohibited for any athlete in a tested pool, because BPC-157 is named under S0, Non-Approved Substances, on the 2026 WADA Prohibited List, prohibited at all times. Thymosin alpha-1 and KPV are not named, but S0 covers substances without regulatory approval for human use, and live Pepti pages advise tested athletes to confirm with their anti-doping body. A prescription does not change any of this. See is thymosin alpha-1 banned in sports, is KPV banned in sports and peptides for athletes.
FORTIFY Blend for Men
Men who feel run down: what a physician rules out first
Men often come to an immune blend because they feel run down or seem to catch everything. That complaint usually has ordinary causes that come before immunity.
| What it is | How it shows up | Why it comes first |
|---|---|---|
| Obstructive sleep apnoea | Snoring, waking unrefreshed, daytime exhaustion | A sleep problem, not an immune one |
| Thyroid disease | Fatigue, weight change, cold intolerance | Common, findable, not treated by a peptide |
| Iron or B12 problems | Fatigue, brain fog | Findable and directly treatable |
| Early diabetes | Fatigue, thirst, central weight | Its own treatment |
| A diagnosed immune condition | Repeated serious infections | A specialist question with established therapies |
| An active infection | Fever, productive cough, a red and spreading wound | Needs actual treatment today; FORTIFY is not that treatment |
More is in peptides for men over 40 and peptides for immune support.
FORTIFY Blend for Men
What the evidence does not establish
- That four peptides together do more than any one alone. No study has compared the blend with its components.
- A benefit in healthy adults, for frequent colds, slow recovery or general immune support, for any component.
- Any effect specific to men, or any effect on testosterone, muscle or training recovery.
- An effect size or a timeline in humans.
- Long-term safety over years of use.
FORTIFY Blend for Men
Side effects and cautions
Nothing in the published research suggests the profile differs between men and women.
| What is reported or relevant | How often | What to do |
|---|---|---|
| Injection-site redness, itching, mild soreness, occasional bruising | Common | Rotate sites; mention it at follow-up |
| Early nausea or light-headedness | Some people | Tell your care team if it persists |
| A transient headache or tiredness early on | Some people | Usually settles; report it if it does not |
| A flare of an autoimmune or inflammatory skin condition | Theoretical | Message your care team and your specialist |
| Unexplained bleeding or bruising away from the site | Not expected | Stop and contact your physician |
| Facial or throat swelling, widespread rash, difficulty breathing | Rare | Call 911 first, then tell your care team |
| Situation | Why it matters |
|---|---|
| In a drug-testing pool | BPC-157 is prohibited at all times |
| Autoimmune disease or immunosuppressive therapy | Immune modulation needs specialist input |
| Personal history of cancer | Blood-vessel mechanisms of BPC-157 and LL-37 |
| Anticoagulant therapy | BPC-157's animal clotting signals |
| Already on thymosin alpha-1, KPV or BPC-157 | FORTIFY would duplicate components |
More in FORTIFY blend side effects.
FORTIFY Blend for Men
How Pepti supplies FORTIFY, and the alternatives
| Product | What is in it | Typical directions | Price |
|---|---|---|---|
| FORTIFY Blend | 5 mL vial: thymosin alpha-1 1 mg/mL + BPC-157 1 mg/mL + KPV 0.4 mg/mL + LL-37 0.2 mg/mL | 0.25 mL (25 units) subcutaneously once daily Monday through Friday | $289/mo |
| Thymosin Alpha-1 | 5 mL vial: thymosin alpha-1 2 mg/mL (10 mg); also a Pen | Printed on your vial | $249/mo |
| KPV | 5 mL vial: KPV 2 mg/mL (10 mg) | Printed on your vial | $229/mo |
| Thymalin | 5 mL vial: thymalin 1 mg/mL (5 mg) | Printed on your vial | $209/mo |
A FORTIFY vial holds 20 doses, about four weeks, so refills run every 28 days, one vial per fill. FORTIFY is a vial-and-syringe product only. Your physician sets your directions after reviewing your intake, and they are printed on the vial. The dose math is in FORTIFY blend dosage.
Every price is all-in, covering medication, physician review, refill management and shipping, with no membership fee. Pepti is cash-pay and does not bill insurance. Vials arrive as solutions ready to use, with sterile syringes and alcohol prep pads, shipped refrigerated with ice packs.
FORTIFY Blend for Men
Where FORTIFY stands with the FDA
FORTIFY has no regulatory status of its own; the components do. Thymosin alpha-1 was reviewed by the FDA's Pharmacy Compounding Advisory Committee on 4 December 2024, which voted 4 in favour and 17 against adding it to the 503A Bulks List; the FDA has not issued a final determination. BPC-157, KPV and LL-37 were removed from Category 2 of the interim 503A list in April 2026. On 23 July 2026 the committee voted 8 to 6 to recommend adding BPC-157 and KPV; final determinations are pending. LL-37 is scheduled for review before the end of February 2027. Compounded medications are not FDA approved.
FORTIFY Blend for Men
Where to get FORTIFY prescribed
FORTIFY cannot be bought legitimately without a prescription. Sites shipping it without one are selling a research-use-only product, where no pharmacy is accountable for identity, purity, sterility or concentration. The prescription route:
- Complete a free online intake covering your history, medications, testosterone therapy if any, any autoimmune condition or immunosuppressant, whether you are drug tested, and what you want help with.
- A physician licensed in your state reviews it, usually within 24 hours.
- If it is appropriate, a PCAB-accredited, FDA-registered US 503A compounding pharmacy prepares it to that prescription. Lot test results are published at /quality/lab-results.
- It ships refrigerated with your directions printed on the vial.
- Your care team stays reachable for questions and side effects.
The step-by-step guide is how to get FORTIFY blend prescribed online. Bloodwork is not required for any Pepti treatment. If your physician wants labs for your care, they'll ask through your account.
References
What this is based on.
References
- Dominari A, Hathaway Iii D, Pandav K et al.. Thymosin alpha 1: A comprehensive review of the literature · World J Virol (2020) · PMID 33362999
- Dürr UH, Sudheendra US, Ramamoorthy A. LL-37, the only human member of the cathelicidin family of antimicrobial peptides · Biochim Biophys Acta (2006) · PMID 16716248
- Dalmasso G, Charrier-Hisamuddin L, Nguyen HT et al.. PepT1-mediated tripeptide KPV uptake reduces intestinal inflammation · Gastroenterology (2008) · PMID 18061177
- Grönberg A, Mahlapuu M, Ståhle M et al.. Treatment with LL-37 is safe and effective in enhancing healing of hard-to-heal venous leg ulcers: a randomized, placebo-controlled clinical trial · Wound Repair Regen (2014) · PMID 25041740
- Mahlapuu M, Sidorowicz A, Mikosinski J et al.. Evaluation of LL-37 in healing of hard-to-heal venous leg ulcers: A multicentric prospective randomized placebo-controlled clinical trial · Wound Repair Regen (2021) · PMID 34687253
- Lande R, Gregorio J, Facchinetti V et al.. Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide · Nature (2007) · PMID 17873860
Citations are provided for educational purposes. They do not constitute medical advice. Always discuss any peptide protocol with your prescribing physician.
Common questions
FORTIFY Blend for Men, answered.
No study has tested FORTIFY in men or anyone. Thymosin alpha-1 has trials in sick populations with no results reported separately for men; the other three components have mostly animal and cell research.
No. None of the four components is a hormone or a secretagogue, and none is described as acting on the testosterone axis.
Not on its research. It is an immune blend. Men looking for help with an injury usually mean TB-500, a different molecule from thymosin alpha-1.
No interaction is described, but no study has looked at the combination. List both on your intake and tell whoever prescribes your testosterone.
Thymosin alpha-1 changes immune-cell signalling in cell and animal work and has trials in hepatitis B and sepsis. No trial has tested any component for general immune support in healthy men.
Not if they are drug tested. BPC-157 is named under S0 on the 2026 WADA Prohibited List, prohibited at all times.
No. An active infection needs a physician and, where indicated, an actual antibiotic or antiviral. FORTIFY is prescribed for resilience between illnesses, not during one.
None of the four components has male fertility data. Tell your physician if you are trying to conceive with a partner.
They have not been compared. Thymosin alpha-1 alone carries twice the thymosin alpha-1 per vial and comes as a Pen; FORTIFY adds the gut and inflammation components.
At Pepti, FORTIFY is $289 a month, all-in, covering medication, physician review, refill management and shipping.
No. Bloodwork is not required for any Pepti treatment. If your physician wants labs for your care, they'll ask through your account. The free assessment goes to a physician licensed in your state. A consultation does not guarantee a prescription.
Next step
See what a physician recommends for you.
A licensed physician in your state reviews your intake and decides what is appropriate. A consultation does not guarantee a prescription.